These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21722594)

  • 1. Elevated intact proinsulin levels are indicative of Beta-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone.
    Pfützner A; Forst T
    J Diabetes Sci Technol; 2011 May; 5(3):784-93. PubMed ID: 21722594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in nondiabetic patients at cardiovascular risk--the PIOSTAT Study.
    Forst T; Pfützner A; Lübben G; Weber M; Marx N; Karagiannis E; Koehler C; Baurecht W; Hohberg C; Hanefeld M
    Metabolism; 2007 Apr; 56(4):491-6. PubMed ID: 17379006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.
    Pfützner A; Pfützner AH; Larbig M; Forst T
    Diabetes Technol Ther; 2004 Jun; 6(3):405-12. PubMed ID: 15198846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
    Pfützner A; Kann PH; Pfützner AH; Kunt T; Larbig M; Weber MM; Forst T
    Clin Lab; 2004; 50(9-10):567-73. PubMed ID: 15481632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological PPARgamma stimulation in contrast to beta cell stimulation results in an improvement in adiponectin and proinsulin intact levels and reduces intima media thickness in patients with type 2 diabetes.
    Forst T; Hohberg C; Fuellert SD; Lübben G; Konrad T; Löbig M; Weber MM; Sachara C; Gottschall V; Pfützner A
    Horm Metab Res; 2005 Aug; 37(8):521-7. PubMed ID: 16138267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
    Pfützner A; Kunt T; Hohberg C; Mondok A; Pahler S; Konrad T; Lübben G; Forst T
    Diabetes Care; 2004 Mar; 27(3):682-7. PubMed ID: 14988285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic beta-cell area.
    Breuer TG; Menge BA; Banasch M; Uhl W; Tannapfel A; Schmidt WE; Nauck MA; Meier JJ
    Eur J Endocrinol; 2010 Oct; 163(4):551-8. PubMed ID: 20679359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current laboratory parameters in the differential diagnosis of type 2 diabetes mellitus. Proinsulin, adiponectin and others].
    Forst T; Pfützner A
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S268-73. PubMed ID: 17139585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
    Cooper MB; Al Majali K; Bailey CJ; Betteridge DJ
    Clin Endocrinol (Oxf); 2008 May; 68(5):738-46. PubMed ID: 17980009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study.
    Pfützner A; Derwahl M; Jacob S; Hohberg C; Blümner E; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2010 Aug; 12(8):599-604. PubMed ID: 20615100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas.
    Wegner M; Winiarska H; Bobkiewicz-Kozłowska T; Dworacka M
    Cytokine; 2008 Jun; 42(3):312-6. PubMed ID: 18397831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of one year treatment of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
    Derosa G; Maffioli P; Ferrari I; Mereu R; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Salvadeo SA
    Horm Metab Res; 2010 Aug; 42(9):663-9. PubMed ID: 20560108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum pancreatic derived factor (PANDER) with beta-cell dysfunction in type 2 diabetes mellitus.
    Shehata MM; Kamal MM; El-Hefnawy MH; El-Mesallamy HO
    J Diabetes Complications; 2017 Apr; 31(4):748-752. PubMed ID: 28161382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Intact Proinsulin in the Oral Glucose Challenge Sample is an Early Indicator for Future Type 2 Diabetes Development - Case Reports and Evidence from the Literature.
    Pfützner A; Manessis A; Hanna MR; Lewin J
    Clin Lab; 2020 May; 66(5):. PubMed ID: 32390400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone ameliorates endothelial dysfunction in those with impaired glucose regulation among the first-degree relatives of type 2 diabetes mellitus patients.
    Yu X; Chen P; Wang H; Zhu T
    Med Princ Pract; 2013; 22(2):156-60. PubMed ID: 22964975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinsulin/insulin ratio as a predictor of insulin resistance and B-cell dysfunction in obese Egyptians ((insulin resistance & B-cell dysfunction in obese Egyptians)).
    El Shabrawy AM; Elbana KA; Abdelsalam NM
    Diabetes Metab Syndr; 2019; 13(3):2094-2096. PubMed ID: 31235142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory evaluation of a new specific ELISA for intact proinsulin.
    Pfützner A; Pfützner AH; Kann PH; Stute R; Löbig M; Yang JW; Mistry J; Forst T
    Clin Lab; 2005; 51(5-6):243-9. PubMed ID: 15991797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress with thiazolidinediones in the management of type 2 diabetes mellitus.
    Meriden T
    Clin Ther; 2004 Feb; 26(2):177-90. PubMed ID: 15038941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.